From: Cancer patients’ participation in population-based health surveys: findings from the HUNT studies
HUNT1 [n 85,516 (90 %)]a | HUNT2 [n 92,406 (70 %)]a | HUNT3 [n 93,552 (55 %)]a | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
NonCaPers | CaPts | NonCaPers | CaPts | NonCaPers | CaPts | |||||||
Invited | 83,465 | 2051 | 89,301 | 3105 | 89,188 | 4364 | ||||||
Participating | 75,083 | (90 %) | 1837 | (90 %) | 62,899 | (70 %) | 2171 | (70 %) | 48,159 | (54 %) | 2511 | (58 %) |
Sexb | ||||||||||||
Males | 36,915 | (88 %)c | 760 | (89 %) | 29,557 | (66 %) | 931 | (70 %) | 21,822 | (49 %) | 1167 | (57 %) |
Females | 38,168 | (92 %) | 1077 | (90 %) | 33,342 | (75 %) | 1240 | (69 %) | 25,336 | (59 %) | 1344 | (58 %) |
Age (years)b | ||||||||||||
Median (range) | 47 (19–101)d | 69 (22–99)e | 48 (19–104) | 70 (20–95) | 53 (19–101) | 69 (21–96) | ||||||
<70 | 63,782 | (90 %) | 1008 | (91 %) | 53,298 | (71 %) | 1120 | (78 %) | 41,216 | (54 %) | 1396 | (64 %) |
≥70 | 11,301 | (89 %) | 829 | (87 %) | 9601 | (68 %) | 1051 | (63 %) | 6943 | (55 %) | 1115 | (51 %) |
Years since cancer diagnosisb | ||||||||||||
Median (range) | 5.1 (0.2–33) | 6.8 (0.2–44) | 7.0 (0.2–54) | |||||||||
<2 | 397 | (86 %) | 374 | (67 %) | 441 | (46 %) | ||||||
2–5 | 451 | (91 %) | 479 | (68 %) | 531 | (58 %) | ||||||
>5 | 989 | (90 %) | 1318 | (71 %) | 1539 | (58 %) | ||||||
Cancer typeb | ||||||||||||
Breast | 392 | (89 %) | 394 | (71 %) | 501 | (60 %) | ||||||
Colorectal | 245 | (89 %) | 306 | (68 %) | 367 | (55 %) | ||||||
Prostate | 184 | (88 %) | 247 | (66 %) | 438 | (64 %) | ||||||
Lung | 19 | (86 %) | 29 | (59 %) | 48 | (49 %) | ||||||
Melanoma | 102 | (90 %) | 169 | (80 %) | 255 | (61 %) |